Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial - Concepedia

Concepedia

Publication | Open Access

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial

DOI Full Paper Access

548

Citations

30

References

2017

Year

Ari Green, Jeffrey M. Gelfand, Bruce Cree, Carolyn Bevan, W. John Boscardin, Feng Mei, Justin Inman, Sam Arnow, Michael Devereux, Aya Abounasr,

Crossover TrialNeurological DisorderNeurological ProgressClinical TrialsNeurological MonitoringNeurologyMultiple SclerosisMedicineNeurological AssessmentNeuroimmunologyClemastine FumarateHealth Sciences

References

	Year	Citations

Page 1

Page 1